12:00 AM
 | 
May 10, 2010
 |  BC Week In Review  |  Company News  |  Deals

Aragen Bioscience, Cevec deal

Aragen received a non-exclusive, worldwide license to use Cevec's CAP-T expression technology and human CAP cell...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >